Fate Therapeutics, Inc. Competitors

FATE 
$6.19
*  
0.29
4.92%
Get FATE Alerts
*Delayed - data as of May 22, 2015  -  Find a broker to begin trading FATE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Fate Therapeutics, Inc.

CompanyName
Symbol: Market
LastSale NetChange Volume Today's High / ▼ Low 52 Weeks High / Low P / E Ratio Market Cap
Biogen Inc.
BIIB: NASDAQ-GS
$ 398.68 -2.47 ▼ 829,439 $ 401.7899
$ 397.40
$ 480.18
$ 290.85
28.76 93,535,909,520
Synageva BioPharma Corp.
GEVA: NASDAQ-GS
$ 218.11 2.32 ▲ 862,930 $ 218.80
$ 214.94
$ 216.90
$ 60.19
NE 8,060,909,380
bluebird bio, Inc.
BLUE: NASDAQ-GS
$ 178.38 5.44 ▲ 994,970 $ 179.48
$ 166
$ 186.36
$ 20.01
NE 5,809,123,080
Amgen Inc.
AMGN: NASDAQ-GS
$ 163.58 -0.26 ▼ 1,634,558 $ 164.57
$ 163.03
$ 173.60
$ 113.01
22.08 124,134,482,380
Gilead Sciences, Inc.
GILD: NASDAQ-GS
$ 111.71 0.49 ▲ 12,075,786 $ 112.66
$ 110.70
$ 116.83
$ 78.50
12.68 166,381,097,420
China Biologic Products, Inc.
CBPO: NASDAQ-GS
$ 109.24 1.37 ▲ 57,645 $ 109.26
$ 107.6955
$ 107.99
$ 37.50
37.67 2,693,530,680
Bio-Techne Corp
TECH: NASDAQ-GS
$ 102.61 -0.15 ▼ 87,132 $ 103.38
$ 102.04
$ 103.19
$ 85.96
35.38 3,810,319,740
Spark Therapeutics, Inc.
ONCE: NASDAQ-GS
$ 67.53 -0.92 ▼ 198,149 $ 69
$ 66.09
$ 79.50
$ 40.16
NE 1,657,456,320
Kite Pharma, Inc.
KITE: NASDAQ-GS
$ 52.85 0.54 ▲ 1,100,449 $ 53.21
$ 51.66
$ 89.21
$ 21
NE 2,247,234,850
Juno Therapeutics, Inc.
JUNO: NASDAQ-GS
$ 46.78 0.44 ▲ 697,274 $ 47.1465
$ 45.58
$ 66
$ 34.71
NE 4,230,128,280
Seattle Genetics, Inc.
SGEN: NASDAQ-GS
$ 43.23 -0.53 ▼ 874,141 $ 44.3899
$ 42.8001
$ 44.95
$ 30.05
NE 5,374,310,370
Neurocrine Biosciences, Inc.
NBIX: NASDAQ-GS
$ 42.55 0.57 ▲ 1,276,223 $ 43.67
$ 41.98
$ 45.36
$ 12.6325
NE 3,625,515,300
Repligen Corporation
RGEN: NASDAQ-GS
$ 40.88 -0.31 ▼ 248,463 $ 41.71
$ 40.60
$ 42.43
$ 18.23
194.67 1,337,675,360
Avalanche Biotechnologies, Inc.
AAVL: NASDAQ-GM
$ 38.03 -0.80 ▼ 204,109 $ 39.30
$ 37.58
$ 62.48
$ 22
NE 955,427,690
Atara Biotherapeutics, Inc.
ATRA: NASDAQ-GS
$ 37.73 0.40 ▲ 177,107 $ 38.29
$ 36.83
$ 64.35
$ 9.66
NE 919,102,800
Cellular Biomedicine Group, Inc.
CBMG: NASDAQ-GM
$ 35.64 4.51 ▲ 469,143 $ 38.15
$ 31.76
$ 49
$ 9
NE 391,861,800
Cellectis S.A.
CLLS: NASDAQ-GM
$ 34 3.20 ▲ 1,688,539 $ 37.47
$ 31.765
$ 42.04
$ 30.40
NE 1,120,946,000
Acceleron Pharma Inc.
XLRN: NASDAQ-GM
$ 32.92 -0.11 ▼ 104,756 $ 33.33
$ 32.44
$ 48.50
$ 23.61
NE 1,061,768,760
Acorda Therapeutics, Inc.
ACOR: NASDAQ-GS
$ 32.01 -0.25 ▼ 476,003 $ 32.19
$ 31.92
$ 45.45
$ 28.26
97 1,362,825,750
Heska Corporation
HSKA: NASDAQ-CM
$ 30 0.01 ▲ 42,682 $ 30.81
$ 29.51
$ 31.87
$ 10.38
65.22 189,600,000
aTyr Pharma, Inc.
LIFE: NASDAQ-GS
$ 24.495 0.50 ▲ 73,484 $ 25.97
$ 23
$ 27.82
$ 12.90
NE 552,362,250
Coherus BioSciences, Inc.
CHRS: NASDAQ-GM
$ 24.98 -0.28 ▼ 210,321 $ 25.44
$ 24.62
$ 33.30
$ 12.27
NE 945,268,180
DBV Technologies S.A.
DBVT: NASDAQ-GS
$ 24.66 -0.43 ▼ 98,361 $ 25.20
$ 24.6299
$ 28.50
$ 20.2601
NE 955,451,700
Qiagen N.V.
QGEN: NASDAQ-GS
$ 25.11 0.06 ▲ 408,427 $ 25.20
$ 24.89
$ 25.91
$ 20.73
53.43 5,859,544,050
Momenta Pharmaceuticals, Inc.
MNTA: NASDAQ-GS
$ 19.88 0.57 ▲ 785,540 $ 19.91
$ 19.08
$ 20.75
$ 9.38
NE 1,092,863,240